Cigna Corp. likely to acquire Express Scripts for over $50 billion
Category: #world  By Dhananjay Punekar  Date: 2018-03-08
  • share
  • Twitter
  • Google Plus
  • Facebook
  • LinkedIn

Cigna Corp. likely to acquire Express Scripts for over $50 billion

The United States based health insurance firm Cigna Corporation has apparently declared its intention to buy Express Scripts Holding Company. The largest pharmacy benefit firm in the U.S. is likely to be sold out for a valuation of around USD 54 billion in a cash & stock agreement.

As per medical industry experts, this strategic decision is aimed at reducing the rising healthcare expenditure and improving Cigna’s product & service offering across the healthcare sector. For the record, Cigna’s offer includes USD 48.75 in cash and 0.2434 shares of stock of the combined entity for every share of Express Scripts. It amounts to nearly USD 96.03 per share, which displays a premium of about 31% to the closing market price of Express.

Reports cite that the announcement of the purchase deal between Cigna & Express follows right after the USD 69 billion merger of the U.S. based health insurance firm Aetna Inc. with CVS Health Corporation, a U.S. retail pharmacy & healthcare firm. The mergers & acquisition deals taking place across the healthcare sector display a shift toward major consolidation, claim experts. Elaborating further, they say that these transactions between medical magnates will help bring pharmacy & medical claims under one roof and enhance preventative measures across the hospitals.

After the finalization of the agreement, Cigna Inc.’s investors will possess the ownership of nearly 64% of the shares of the joint entity, while the stakeholders of Express Scripts will own the remaining shares. The key officials of Cigna have announced that the firm is likely to fund the cash for the agreement through Express Scripts’ outstanding debts, new debt issuances, and cash on hand.

As per the company sources, it has already received complete debt financing from The Bank of Tokyo-Mitsubishi UFJ Limited and Morgan Stanley Senior Funding. Incidentally, the deal is valued at a total of USD 67 billion, including close to USD 15 billion in Express Scripts' debts.



About Author

Dhananjay Punekar

Email: dhananjay.p@news.marketsizeforecasters.com   

Dhananjay Punekar

Dhananjay Punekar presently develops content for a slew of portals, including Market Size Forecasters and Algosonline. A post graduate in mathematics and business administration, he worked in Infosys BPO Limited prior to switching his professional genre. As a content wr...

Read More

More News By Dhananjay Punekar

AstraZeneca & Emulate to bring advanced organ-on-chip tech in labs
AstraZeneca & Emulate to bring advanced organ-on-chip tech in labs
By Dhananjay Punekar

AstraZeneca Plc, a biopharma firm headquartered in the UK, has entered into a collaboration with Emulate Inc. to include organ-on-a-chip technology into its R&D program. As per authentic sources, the strategic move...

German court bans old diesel cars on roads with immediate effect
German court bans old diesel cars on roads with immediate effect
By Dhananjay Punekar

Germany’s top administrative court, in a surprise move, has apparently directed city authorities to prohibit the older diesel-driven cars from running on the streets right away. Sources cite that the decision had...

EDF sounds out bidders for a 49% stake in its wind farm business
EDF sounds out bidders for a 49% stake in its wind farm business
By Dhananjay Punekar

EDF Energy, an integrated French energy firm headquartered in the UK, is apparently trying to raise funds through the sale of nearly 49% of its stake in its wind farm business. For the record, the firm is one of the co...